Get the best news & discounts for Broadway Shows & beyond.
Stealth BioTherapeutics' filing for rare disease drug elamipretide has been turned down by the FDA, although the company says the US regulator has given it a "path forward" for the programme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback